Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care.
Doidge, JC; Gould, DW; SADIQUE, Z; Borthwick, M; Hatch, RA; Caskey, FJ; Forni, L; Lawrence, RF; MacEwan, C; Ostermann, M; Mouncey, PR; Harrison, DA; Rowan, KM; Young, JD; Watkinson, PJ;
2022
Journal of critical care, (2022).74, 10.1016/j.jcrc.2022.154218.
Equity analysis of the impacts of COVID-19 strategies across six countries.
SWEENEY, S;
2022
(2022).
Cost-effectiveness of PRACTECAL regimens for MDR-TB.
SWEENEY, S;
2022
(2022).
How does power shape district health management team responsiveness to public feedback in low- and middle-income countries: an interpretive synthesis.
Kagwanja, N; Molyneux, S; Whyle, E; Tsofa, B; GILSON, L;
2022
Health policy and planning, (2022).38 4 10.1093/heapol/czac105.
Exploring uncertainty and use of real-world data in the National Institute for Health and Care Excellence single technology appraisals of targeted cancer therapy.
KANG, J; CAIRNS, J;
2022
BMC cancer, (2022).22 1 10.1186/s12885-022-10350-8.
Efficiency of TB service provision in the public and private health sectors in Ethiopia.
Minwyelet Terefe, M; Eyob, H; Letta, T; Nadew, E; Assefa, T; Hailu, B; Cunnama, L; Garcia Baena, I; VASSALL, A; SWEENEY, S; Laurence, YV;
2022
International Journal of Tuberculosis and Lung Disease, (2022).26 12 10.5588/ijtld.21.0481.
Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacteriumulcerans disease, a protocol for a randomised controlled trial in Ghana.
Amoako, YA; Agbanyo, A; Novignon, J; Owusu, L; Tuffour, J; Asante-Poku, A; Hailemichael, Y; MOSWEU, I; Canter, R; OPONDO, C; ALLEN, E; PITT, C; Yeboah-Manu, D; WALKER, SL; MARKS, M; Phillips, RO; SHARP collaboration,;
2022
NIHR Open Research, (2022).2, 10.3310/nihropenres.13332.2.
Extensions of Health Economic Evaluations in R for Microsoft Excel Users: A Tutorial for Incorporating Heterogeneity and Conducting Value of Information Analyses.
NAYLOR, NR; Williams, J; Green, N; Lamrock, F; BRIGGS, A;
2022
PharmacoEconomics, (2022).41 1 10.1007/s40273-022-01203-0.
Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study.
Li, X; HODGSON, D; Flaig, J; Kieffer, A; Herring, WL; Beyhaghi, H; Willem, L; JIT, M; Bilcke, J; Beutels, P; REspiratory Syncytial virus Consortium in EUrope (,;
2022
Value in health, (2022).26 4 10.1016/j.jval.2022.11.014.
Evaluating the impact of Respiratory Syncytial Virus immunisation strategies on antibiotic use and drug resistant bacterial infections in England.
ATKINS, KE; Hodgson, D; Jit, M; DAVIES, NG;
2022
Wellcome Open Research, (2022).7, 10.12688/wellcomeopenres.18183.1.